Jennifer G Goldman

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. ncbi Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
  2. ncbi Treatment of dystonia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
    Clin Neuropharmacol 26:102-8. 2003
  3. ncbi Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 61:1280-4. 2004
  4. ncbi Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2248-50. 2008
  5. ncbi An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Jennifer G Goldman
    Rush University Medical Center, Department of Neurological Sciences, 1725 W Harrison Street, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:2009-24. 2011
  6. ncbi Mild cognitive impairment in Parkinson's disease
    J G Goldman
    Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
    Minerva Med 102:441-59. 2011
  7. ncbi Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:727-34. 2012
  8. ncbi Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012

Detail Information

Publications8

  1. ncbi Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
    ..Furthermore, increased burden of cognitive dysfunction, rather than type of cognitive deficit, may be associated with greater motor impairment in PD-MCI...
  2. ncbi Treatment of dystonia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
    Clin Neuropharmacol 26:102-8. 2003
    ..Studies in functional outcome and quality of life further support the importance of discovering safe and effective means to treat dystonia. An algorithmic approach may be useful to guide the physician along the various treatment choices...
  3. ncbi Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 61:1280-4. 2004
    ..Because CCK gene polymorphisms vary across ethnic groups, the presence of similar associations in white PD subjects merits investigation...
  4. ncbi Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2248-50. 2008
    ..Our results suggest that dopaminergic medications have limited benefit in DLB because of the low likelihood of motor improvement and the risk of psychosis exacerbation...
  5. ncbi An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Jennifer G Goldman
    Rush University Medical Center, Department of Neurological Sciences, 1725 W Harrison Street, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:2009-24. 2011
    ..These strategies also have challenges but have the potential to enhance our understanding of PD psychosis and advance the development of agents that can ultimately be tested in well-designed, randomized, controlled trials...
  6. ncbi Mild cognitive impairment in Parkinson's disease
    J G Goldman
    Section of Parkinson Disease and Movement Disorders, Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
    Minerva Med 102:441-59. 2011
    ..Future studies using uniform PD-MCI diagnostic criteria and incorporating biomarkers and longitudinal follow-up of PD-MCI cohorts are needed to understand PD-MCI as a transitional state between normal cognition and dementia...
  7. ncbi Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:727-34. 2012
    ..Thus, ERC atrophy on MRI may be a potential biomarker for dementia in PD, particularly in the setting of memory impairment...
  8. ncbi Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012
    ..Revision of the checklist by altering or eliminating the 2 problematic checklist items may improve sensitivity...